Buy 5-Bromo-DMT Powder

Product Overview

5-Bromo-DMT Powder offers 5-bromo-N,N-dimethyltryptamine (5‑Br‑DMT) as a high-purity indole-based research chemical for professional laboratory environments. As the 5‑bromo analogue of N,N-dimethyltryptamine, this compound is of interest in analytical, structural, and receptor-focused research, and has also been encountered as a novel designer tryptamine in monitoring and forensic contexts.

The material is supplied as a brandless crystalline solid with a purity specification of ≥98%, oriented toward non-clinical uses such as analytical reference work, assay development, and structure–activity investigations. It is not developed, presented, or supported as a pharmaceutical, dietary, or consumer product, and all handling must occur within controlled laboratory settings operated by trained personnel. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Chemical Identity & Classification

5-Bromo-DMT is chemically defined as 5-bromo-N,N-dimethyltryptamine, a substituted tryptamine featuring a bromo substituent at the 5-position of the indole ring and a dimethylated ethylamine side chain. It is the 5‑bromo derivative of DMT and has been reported as a naturally occurring marine tryptamine as well as a synthetic new psychoactive substance.

Key identifiers include:

• Preferred name: 5-bromo-N,N-dimethyltryptamine (5-Bromo-DMT, 5‑Br‑DMT)

• CAS number: 17274-65-6

• Molecular formula: C12H15BrN2

• Molecular weight: ~267.16–267.17 g/mol

• Representative synonyms: 5-bromo-N,N-DMT; BDT; 2-(5-bromo-1H-indol-3-yl)-N,N-dimethylethanamine; 5-bromo-N,N-dimethyltryptamine.

Within research, 5-Bromo-DMT Powder is typically classified as:

• A synthetic tryptamine-class research chemical and analytical reference standard.

• A small-molecule indole derivative used in non-clinical structural, receptor, and analytical investigations.

Chemical & Physical Characteristics

Reference-standard catalogues describe 5-bromo-N,N-DMT as a crystalline solid supplied neat, with the molecular formula C12H15BrN2 and a calculated molecular weight of approximately 267.16 g/mol. As a substituted indole, the molecule contains an aromatic indole core, a bromo substituent at the 5-position, and a dimethylated ethylamine side chain, which together influence its lipophilicity, basicity, and salt-forming behavior.

Computed and catalogued data indicate that 5‑bromo-N,N-DMT is a low-volatility solid under standard conditions, amenable to handling as a crystalline powder for preparation of analytical solutions and reference standards. Solubility information from chemical suppliers notes compatibility with polar organic solvents such as DMSO, DMF, and ethanol for preparation of concentrated stock solutions, while aqueous solubility is typically enhanced via appropriate solvent systems or salt formation. Lot-specific details such as precise appearance, color, and melting behavior are usually documented in the certificate of analysis (COA) associated with each batch.

Purity & Analytical Verification

5-Bromo-DMT Powder is specified at ≥98% purity, consistent with analytical reference standards and high-grade research chemicals. This purity level supports advanced analytical workflows where trace impurities may affect chromatographic behavior, spectral readouts, or quantitative results.

Supplier information identifies 5‑bromo-N,N-DMT as an analytical reference standard, indicating that identity and purity are confirmed using validated techniques such as high-performance liquid chromatography (HPLC), mass spectrometry, and spectroscopic methods. Public chemical databases provide structural and computed property data (e.g., formula, molecular weight, InChI, SMILES) that align with these reference materials and support structural verification. A batch-specific COA summarizing assay, impurity limits, and key analytical tests is typically available to qualified laboratories for audit and quality documentation.

Quality Control & Batch Integrity

Reference-standard suppliers maintain batch-controlled production of 5-bromo-DMT, assigning unique lot identifiers to each crystalline batch to ensure traceability from synthesis through packaging. This framework allows users to link the material they receive directly to its supporting COA, safety information, and any additional technical data.

Quality programs for such standards typically encompass identity confirmation, purity testing, appearance checks, and verification that packaging and labeling conform to internal specifications and regulatory expectations. For use in regulated or quality-managed environments, documented methods and acceptance criteria provide confidence in lot-to-lot consistency and analytical performance.

Safety, Handling & Laboratory Precautions

5-Bromo-DMT Powder is intended exclusively for handling by trained professionals in properly equipped laboratory settings. Standard good laboratory practice (GLP) should be followed, including use of appropriate personal protective equipment such as gloves, protective eyewear, and lab coats, and, where required, working within fume hoods or other engineering controls.

Substance summaries identify 5‑Br‑DMT as a psychoactive tryptamine and note receptor interactions in preclinical research, underscoring the need for controlled handling and robust risk assessment even in non-clinical settings. Users should consult the product’s safety data sheet (SDS) for detailed information on hazard classification, exposure controls, spill-response procedures, and disposal guidelines, and must ensure that internal procedures and local regulations are followed. No instructions or implications are provided for any form of administration or in vivo use; work with this material must remain within strictly non-clinical research boundaries.

Packaging, Labeling & Storage

5-Bromo-DMT research material is supplied as a crystalline solid in sealed, research-grade primary containers designed to protect the compound from moisture, light, and physical damage during transport and storage. Packaging for analytical standards is typically robust and may incorporate tamper-evident features to allow verification of integrity upon receipt.

Labels customarily include the analyte name (5-bromo-N,N-DMT), CAS number (17274‑65‑6), molecular formula, molecular weight, lot number, and key hazard or precautionary statements, enabling accurate cataloging and compliant handling within laboratory inventory systems. Supplier and database entries indicate that storage at low temperature (for example, in a freezer) and protection from light are appropriate for maintaining stability of indole-based reference standards. The SDS and COA for each batch should be treated as primary sources for precise storage conditions and shelf-life or re‑test guidance, and access should be restricted to authorized personnel only.

Intended Research Use & Market Positioning

5-Bromo-DMT Powder is positioned strictly as a research and analytical reference chemical for professional laboratory use. It may be relevant to analytical chemistry, receptor and structure–activity studies, marine natural products research, and method development involving brominated tryptamine derivatives where such activities are legally permitted and appropriately approved.

The product is not manufactured, approved, or marketed for human or veterinary use and is not intended for clinical, diagnostic, or consumptive applications. Any discussion of psychoplastogenic or pharmacological properties in the scientific literature relates to separate, controlled research contexts and does not alter the strictly research-only positioning of this material. End users are responsible for ensuring that work with 5‑bromo‑DMT complies with all applicable institutional policies and regulatory requirements.

Ordering, Availability & Fulfillment

5-Bromo-DMT crystalline material is offered through specialized reference-standard and research-chemical supply channels to verified institutional and professional customers. Product documentation typically includes analyte name, CAS number, catalog code, lot number, and packing format, supporting accurate procurement records and inventory traceability.

Availability may be influenced by production runs, demand from analytical and receptor-research communities, and any regional or institutional restrictions affecting brominated tryptamine derivatives. Shipments are generally prepared in robust outer packaging suitable for courier or cold-chain transport as required, with tracked delivery options to support chain-of-custody documentation for sensitive or controlled materials. Technical and customer support can normally provide COAs, SDS documents, and product-specification clarification within strict non-clinical, research-only boundaries.

Legal & Regulatory Disclaimer

This product is supplied strictly as a research chemical for use in laboratory environments by qualified professionals operating under appropriate institutional and regulatory oversight. It is not manufactured, approved, or intended for human or veterinary use and must not be used for clinical, diagnostic, therapeutic, or consumptive applications under any circumstances.

Responsibility for compliance with all applicable local, national, and international laws—including scheduling, licensing, import/export, and controlled-substance regulations relating to 5-bromo-N,N-dimethyltryptamine—rests solely with the purchaser and end user. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.